Q-omics provides the consensus-scored MTND2P6 profile across patient tissues and cancer cell-line models. MTND2P6 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, MTND2P6 RNA expression shows 7,533 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight MESO, and TGCT as cancer lineages where MTND2P6 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.